HALEIGH TAYLOR: Open Payments
NPI 1144894684 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,826 in 65 payments from 33 companies in 2025. Trend: 2023 $1,938 · 2024 $1,524 · 2025 $1,826
Food & beverage: $1,698Education: $128
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $226 |
| Gilead Sciences, Inc. | 2 | $195 |
| ABBVIE INC. | 6 | $163 |
| Merck Sharp & Dohme LLC | 3 | $149 |
| Incyte Corporation | 4 | $147 |
| Janssen Biotech, Inc. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 3 | $90 |
| Eisai Inc. | 3 | $70 |
| PFIZER INC. | 3 | $60 |
| Genentech USA, Inc. | 3 | $60 |
Products named: Trodelvy, KEYTRUDA, CALQUENCE, ERLEADA, Lenvima, VENCLEXTA, SCEMBLIX, JAKAFI.
Industry payments across SC — which companies pay providers there.
